Projects
The pharmaceutical projects listed in this phase are those that receive periodic global announcements.
Meissner to Build New Manufacturing Facility in USA
Meissner Corporation has invested US$250 million in the development of a new manufacturing site in AthensClarke County, Georgia, USA
Aytu BioPharma Subleases a Portion of Its Manufacturing Facility in USA
Aytu BioPharma and AMT Manufacturing Solutions have recently reached an agreement regarding the subleasing of a portion of Aytus manufacturing facility located in Grand Prairie, Texas, in the United States
Amgen to Start Construction of a New Bio Manufacturing Facility in the USA
Amgen, a biotechnology leader, has announced plans to construct a new biomanufacturing facility in Holly Springs, North Carolina, USA
Samsung Biologics to Start Construction of a New US$ 1billion Manufacturing Plant
Samsung Biologics has announced that it will invest US$1 billion in the construction of its manufacturing plant at the Songdo site in South Korea
Takeda Invests US$764 million for Plasma-Derived Manufacturing Facility in Japan
Takeda, a global pharmaceutical and biotechnology leader, is investing US$764 million to build a new manufacturing facility for plasmaderived therapies PDTs in Osaka, Japan
Lonza's Early Development Services Offering Expanding Into North America
Lonza has announced plans to establish a new laboratory in Cambridge, Massachusetts US, in an effort to broaden the scope of its Early Development Services EDS in North America The nearby Boston biotech communitys 17,000 square foot centre broadens Lonzas current EDS product range
Lilly Plans to invest US $450 million at a US Manufacturing Site
Eli Lilly plans to invest US $450 million in a facility in the Research Triangle Park area of the United States, to expand its manufacturing capabilities To meet the growing demand for Lillys incretinbased diabetes treatments, the expansion includes more parenteral filling, device assembly, and packaging capacity
AtomVie Starts Construction of a New Radiopharmaceutical CDMO Facility in Canada
AtomVie Global Radiopharma Inc AtomVie has started the construction of a new radiopharmaceutical stateoftheart facility in Hamilton, Ontario, Canada AtomVies new 64,000 square foot facility, which is currently situated on the grounds of McMaster University, will be used exclusively for the high volume clinical and commercial
Agilent Technologies Invests US $725 million on Manufacturing Facility Expansion in USA
Agilent Technologies invested $725 million, to double the facility in Frederick, Colorados manufacturing capability for therapeutic nucleic acids A increasing number of diseases, including cancer, cardiovascular disease, rare diseases, and infectious diseases, require the use of active pharmaceutical
Ardena to Expand Manufacturing Facility in Sweden
Ardena is nearly tripling the size of its Swedish facility, as part of a US $ 37 million investment across its European operations The company is making investments in the production of drug substances in Sdertlje in order to increase capacity These include a new production line, a larger preparative High
